Latest News and Press Releases
Want to stay updated on the latest news?
- 
                            
Ottawa, Oct. 10, 2025 (GLOBE NEWSWIRE) -- The global precision medicine market size was valued at USD 101.86 billion in 2024 and is predicted to hit around USD 463.11 billion by 2034, rising at a...
 - 
                            
LOS ANGELES, Aug. 21, 2025 (GLOBE NEWSWIRE) -- AgTech Breakthrough, a leading market intelligence organization that recognizes the top companies, technologies and products in the global agricultural...
 - 
                            Agricultural and Food Technology Innovators Honored in 5th Annual AgTech Breakthrough Awards Program
LOS ANGELES, Aug. 21, 2025 (GLOBE NEWSWIRE) -- AgTech Breakthrough, a leading market intelligence organization that recognizes the top companies, technologies and products in the global agricultural...
 - 
                            
LOS ANGELES, Aug. 07, 2025 (GLOBE NEWSWIRE) -- The 2025 Pet Innovation Awards today announced that the Tweezerman Pet Collection has been recognized with “Grooming Product of the Year” in the 7th...
 - 
                            
Austin, TX, USA, July 30, 2025 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “CNC Metal Cutting Machine Tools Market Size, Trends and Insights By Type (Metal...
 - 
                            
Valiantys, announced the launch of its new consulting framework, Valiantys Precision, designed to accelerate enterprise IT transformation.
 - 
                            
RICHMOND, Ind., May 07, 2025 (GLOBE NEWSWIRE) -- Liberation Labs today announced a manufacturing partnership with Dutch ingredients startup Vivici. Liberation Labs will produce Vivici’s flagship...
 - 
                            
March 6, 2025 Biodexa Announces Appointment of Precision for Medicine LLC as CRO for European Component of Phase 3 Study of eRapa in FAP Biodexa is finalizing plans to initiate an international...
 - 
                            
COPENHAGEN, Denmark, December 2, 2024 - Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, will present...
 - 
                            
Improved precision of the AI-Immunology™ platform in predicting clinically relevant vaccine targets boosts the potential of its AI-derived vaccine candidates The improvement has been achieved through...